Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hamzaoui

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Clinical Rheumatology|March 1, 1989
Treatment of Behçet's disease with dapsoneM Hamza, K Hamzaoui, K Ayed
Current Molecular Medicine|March 27, 2018
Update on Asthma Genetics: Results From Meta-Analyses of Candidate Gene Association StudiesK Tizaoui, K Hamzaoui, A Hamzaoui
The Journal of Rheumatology|May 1, 1992
Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodiesA Kahan, K Hamzaoui, K Ayed
Clinical and Experimental Rheumatology|October 28, 2006
CD4+CD25+ regulatory T cells in patients with Behçet's diseaseK Hamzaoui, A Hamzaoui, H Houman
Mediators of Inflammation|March 7, 2000
Lymphocytes apoptosis in patients with acute exacerbation of asthmaA Hamzaoui, K Hamzaoui, H Salah, et al.
Clinical and Experimental Rheumatology|March 1, 1991
Suppressive T cell function of Epstein-Barr virus induced B cell activation in active Behçet's diseaseK Hamzaoui, A Kahan, M Hamza, et al.
Clinical and Experimental Rheumatology|November 9, 2005
Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestationsK Hamzaoui, A Hamzaoui, L Bouajina, et al.
Mediators of Inflammation|January 1, 1996
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritisA Hamzaoui, K Hamzaoui, A Kahan, et al.
British Journal of Rheumatology|April 1, 1996
Endothelin-1 expression in serum and bronchoalveolar lavage from patients with active Behçet's diseaseA Hamzaoui, K Hamzaoui, A Chabbou, et al.
La Tunisie Medicale|March 21, 1998
Soluble adhesion molecules and sCD27 levels in patients with asthmaA Hamzaoui, K Hamzaoui, K Ayed, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Clinical Rheumatology|March 1, 1989
Treatment of Behçet's disease with dapsoneM Hamza, K Hamzaoui, K Ayed
Current Molecular Medicine|March 27, 2018
Update on Asthma Genetics: Results From Meta-Analyses of Candidate Gene Association StudiesK Tizaoui, K Hamzaoui, A Hamzaoui
The Journal of Rheumatology|May 1, 1992
Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodiesA Kahan, K Hamzaoui, K Ayed
Clinical and Experimental Rheumatology|October 28, 2006
CD4+CD25+ regulatory T cells in patients with Behçet's diseaseK Hamzaoui, A Hamzaoui, H Houman
Mediators of Inflammation|March 7, 2000
Lymphocytes apoptosis in patients with acute exacerbation of asthmaA Hamzaoui, K Hamzaoui, H Salah, et al.
Clinical and Experimental Rheumatology|March 1, 1991
Suppressive T cell function of Epstein-Barr virus induced B cell activation in active Behçet's diseaseK Hamzaoui, A Kahan, M Hamza, et al.
Clinical and Experimental Rheumatology|November 9, 2005
Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestationsK Hamzaoui, A Hamzaoui, L Bouajina, et al.
Mediators of Inflammation|January 1, 1996
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritisA Hamzaoui, K Hamzaoui, A Kahan, et al.
British Journal of Rheumatology|April 1, 1996
Endothelin-1 expression in serum and bronchoalveolar lavage from patients with active Behçet's diseaseA Hamzaoui, K Hamzaoui, A Chabbou, et al.
La Tunisie Medicale|March 21, 1998
Soluble adhesion molecules and sCD27 levels in patients with asthmaA Hamzaoui, K Hamzaoui, K Ayed, et al.
Pageof 7